-
1
-
-
84875727940
-
Epigenetics as a therapeutic target in breast cancer
-
Connolly R, Stearns V (2012). Epigenetics as a therapeutic target in breast cancer. J Mammary Gland Biol Neoplasia, 17, 191-204.
-
(2012)
J Mammary Gland Biol Neoplasia
, vol.17
, pp. 191-204
-
-
Connolly, R.1
Stearns, V.2
-
2
-
-
84874083022
-
Standardized breast cancer mortality rate compared to the general female population of Iran
-
Haghighat S, Akbari M, Ghaffari S (2012). Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev, 13, 5525-8.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 5525-5528
-
-
Haghighat, S.1
Akbari, M.2
Ghaffari, S.3
-
3
-
-
84871549520
-
MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis
-
Harquail J, Benzina S, Robichaud GA (2012). MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomark, 11, 269-80.
-
(2012)
Cancer Biomark
, vol.11
, pp. 269-280
-
-
Harquail, J.1
Benzina, S.2
Robichaud, G.A.3
-
4
-
-
80755173292
-
Epigenetics in breast cancer: what's new
-
Huang Y, Nayak S, Jankowitz R, et al (2011). Epigenetics in breast cancer: what's new? Breast Cancer Res, 13, 225-35.
-
(2011)
Breast Cancer Res
, vol.13
, pp. 225-235
-
-
Huang, Y.1
Nayak, S.2
Jankowitz, R.3
-
5
-
-
84880347611
-
MicroRNAs: an emerging science in cancer epigenetics
-
Kala R, Peek GW, Hardy TM, et al (2013). MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinforma, 16, 6-13.
-
(2013)
J Clin Bioinforma
, vol.16
, pp. 6-13
-
-
Kala, R.1
Peek, G.W.2
Hardy, T.M.3
-
6
-
-
78449302631
-
Deregulation of miR- 519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours
-
Kim TH, Kim YK, Kwon Y, et al (2010). Deregulation of miR- 519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology, 57, 734-43.
-
(2010)
Histopathology
, vol.57
, pp. 734-743
-
-
Kim, T.H.1
Kim, Y.K.2
Kwon, Y.3
-
7
-
-
84860317269
-
MicroRNAs: molecular features and role in cancer
-
Lages E, Ipas H, Guttin A, et al (2012). MicroRNAs: molecular features and role in cancer. Front Biosci, 17, 2508-40.
-
(2012)
Front Biosci
, vol.17
, pp. 2508-2540
-
-
Lages, E.1
Ipas, H.2
Guttin, A.3
-
8
-
-
84873532166
-
Post-transcriptional stimulation of gene expression by microRNAs
-
Lee S, Vasudevan S (2013). Post-transcriptional stimulation of gene expression by microRNAs. Adv Exp Med Biol, 768, 97-126.
-
(2013)
Adv Exp Med Biol
, vol.768
, pp. 97-126
-
-
Lee, S.1
Vasudevan, S.2
-
9
-
-
84875376648
-
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation
-
Li S, Meng H, Zhou F, et al (2013). MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract, 209, 179-83.
-
(2013)
Pathol Res Pract
, vol.209
, pp. 179-183
-
-
Li, S.1
Meng, H.2
Zhou, F.3
-
10
-
-
84864085607
-
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression
-
Lindström LS, Karlsson E, Wilking UM, et al (2012). Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. J Clin Oncol, 30, 2601-8.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2601-2608
-
-
Lindström, L.S.1
Karlsson, E.2
Wilking, U.M.3
-
11
-
-
84874115389
-
Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue
-
Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, et al (2013). Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac J Clin Oncol, 9, 53-9.
-
(2013)
Asia Pac J Clin Oncol
, vol.9
, pp. 53-59
-
-
Mar-Aguilar, F.1
Luna-Aguirre, C.M.2
Moreno-Rocha, J.C.3
-
12
-
-
84875178612
-
MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer
-
OzgÜn A, Karagoz B, Bilgi O, et al (2013). MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer. Onkologie, 36, 115-8.
-
(2013)
Onkologie
, vol.36
, pp. 115-118
-
-
OzgÜn, A.1
Karagoz, B.2
Bilgi, O.3
-
13
-
-
84880362470
-
microRNA Regulation and Its Consequences in Cancer
-
Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep, 1, 71-9.
-
(2013)
Curr Pathobiol Rep
, vol.1
, pp. 71-79
-
-
Parpart, S.1
Wang, X.W.2
-
14
-
-
84855792427
-
Cancer statistics, 2012
-
Siegel R, Naishadham D, and Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
-
(2012)
CA Cancer J Clin
, vol.62
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
15
-
-
84874925307
-
Role of microRNAs in breast cancer
-
Singh R, Mo YY (2013). Role of microRNAs in breast cancer. Cancer Biol Ther, 14, 201-12.
-
(2013)
Cancer Biol Ther
, vol.14
, pp. 201-212
-
-
Singh, R.1
Mo, Y.Y.2
-
16
-
-
84870668442
-
The Role of MicroRNAs in Breast Cancer Migration
-
Tang J, Ahmad A, Sarkar FH (2012). The Role of MicroRNAs in Breast Cancer Migration. In J Mol Sci, 13, 13414-37.
-
(2012)
In J Mol Sci
, vol.13
, pp. 13414-13437
-
-
Tang, J.1
Ahmad, A.2
Sarkar, F.H.3
-
17
-
-
84875807408
-
Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer
-
Wu Z, He B, He J, et al (2013). Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate, 73, 596-604.
-
(2013)
Prostate
, vol.73
, pp. 596-604
-
-
Wu, Z.1
He, B.2
He, J.3
-
18
-
-
74049092646
-
Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG
-
Xu J, Liao X, Wong C (2010). Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. Int J Cancer, 126, 1029-35.
-
(2010)
Int J Cancer
, vol.126
, pp. 1029-1035
-
-
Xu, J.1
Liao, X.2
Wong, C.3
-
19
-
-
80052973904
-
Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines
-
Xu J, Liao X, Lu N, et al (2011). Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines. Int J Cancer, 129, 2527-31.
-
(2011)
Int J Cancer
, vol.129
, pp. 2527-2531
-
-
Xu, J.1
Liao, X.2
Lu, N.3
-
20
-
-
84874782064
-
Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer
-
Xu Q, Sun Q, Zhang J, et al (2013). Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis, 34, 539-49.
-
(2013)
Carcinogenesis
, vol.34
, pp. 539-549
-
-
Xu, Q.1
Sun, Q.2
Zhang, J.3
-
21
-
-
84877642391
-
The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008
-
Yang L, Sun TT, Wang N (2012). The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008. Zhonghua Yu Fang Yi Xue Za Zhi, 46, 1009-14.
-
(2012)
Zhonghua Yu Fang Yi Xue Za Zhi
, vol.46
, pp. 1009-1014
-
-
Yang, L.1
Sun, T.T.2
Wang, N.3
-
22
-
-
84878421257
-
MicroRNA-153 is tumor suppressive in glioblastoma stem cells
-
Zhao S, Deng Y, Liu Y, et al (2013). MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol Biol Rep, 40, 2789-98.
-
(2013)
Mol Biol Rep
, vol.40
, pp. 2789-2798
-
-
Zhao, S.1
Deng, Y.2
Liu, Y.3
|